Chen, S., Wu, Y., Weng, J., Zhang, C., Zhou, H., Doronin, V., Hong, M., Wang, Y., Wei, X., Osipov, I., Alexeeva, Y., Chen, Z., Wang, Y., Men, L., Wang, H., Jiang, L., Xiong, D., Yang, D., Zhao, W., Zhai, Y. (2025). Results of POLARIS-1, a global Phase 3 study (Part A): Olverembatinib combined with low-intensity chemotherapy in patients with newly diagnosed (ND) Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). Blood. https://doi.org/10.1182/blood-2025-1574